VK
Viking Therapeutics
VKTX·NASDAQSan Diego CAFounded 201245 employees
Mid CapbiotechPublicMetabolic
Platform: Dual GLP-1/GIP
Market Cap
$6B
All Drugs
4
Clinical Trials
8
Failed / Terminated
3
FDA Approved
1
Stock Price & Catalysts (VKTX)
Loading VKTX stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| VKT-4052 | VKT-4052 | Phase 2/3 | 2 | TNFα | Epilepsy | ||
| VKT-6548 | VKT-6548 | Phase 2/3 | 1 | PD-L1 | Prostate Ca | ||
| Tirasotorasib | VKT-5480 | Phase 1 | 1 | CFTR | MMWet AMD | ||
| Voxaderotide | VKT-2923 | Approved | 4 | PD-L1 | PsA |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (8)